Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.1	8.61	4.11	4.28	4.51	7.82
Cash & Short-Term Investments	7.1	8.61	4.11	4.28	4.51	7.82
Cash Growth	27.98%	109.69%	-4.09%	-4.99%	-42.36%	-5.96%
Accounts Receivable	14.57	16.04	14.87	16.1	16.71	21.83
Inventory	22.21	20.81	23.25	24.72	26.44	27.59
Other Current Assets	3.6	2.76	2.9	3.94	3.47	4.34
Total Current Assets	47.48	48.23	45.12	49.04	51.12	61.58
Net Property, Plant & Equipment	11.6	11.96	11.24	8.75	9.18	10.31
Other Intangible Assets	6.91	7.64	11.13	16.04	21.01	27.39
Goodwill	9.37	9.56	56.32	57.07	56.26	57.69
Other Long-Term Assets	2.58	2.69	2.83	6.47	7.78	5.38
Total Assets	77.94	80.07	126.64	137.37	145.36	162.34
Accounts Payable	5.29	3.65	4.79	5.55	6.45	4.91
Current Portion of Long-Term Debt	-	-	36.96	5.86	3.81	3.24
Current Portion of Leases	-	-	-	-	2.14	2.14
Unearned Revenue	3.67	3.45	3.81	4.51	3.37	4.27
Other Current Liabilities	14.91	14.86	9.41	10.62	7.49	10.76
Total Current Liabilities	23.86	21.96	54.96	26.54	23.25	25.32
Long-Term Debt	36.21	35.87	-	30.7	43.01	45.1
Long-Term Leases	6.36	6.88	6.38	4.79	5.28	6.49
Other Long-Term Liabilities	1.46	1.63	1.97	2.25	1.6	2.04
Total Long-Term Liabilities	44.03	44.38	8.35	37.75	49.89	53.63
Total Liabilities	67.89	66.34	63.3	64.29	73.14	78.94
Common Stock	0.45	0.45	0.44	0.43	0.45	0.45
Additional Paid-in Capital	240.05	239.67	236.58	232.44	229.01	225.65
Accumulated Other Comprehensive Income	-12.31	-11.67	-15.67	-14.19	-15.05	-10.03
Retained Earnings	-218.13	-214.71	-158.01	-145.61	-142.19	-132.67
Shareholders' Equity	10.05	13.73	63.34	73.07	72.22	83.4
Total Liabilities & Equity	77.94	80.07	126.64	137.37	145.36	162.34
Total Debt	42.57	42.75	43.34	41.36	54.24	56.96
Net Cash (Debt)	-35.47	-34.14	-39.23	-37.07	-49.73	-49.14
Net Cash Per Share	-7.96	-7.69	-9.01	-8.74	-12.01	-12.18
Book Value	10.05	13.73	63.34	73.07	72.22	83.4
Book Value Per Share	2.26	3.09	14.55	17.23	17.44	20.67
Tangible Book Value	-6.23	-3.46	-4.12	-0.03	-5.05	-1.67
Tangible Book Value Per Share	-1.40	-0.78	-0.95	-0.01	-1.22	-0.41

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q